Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100015078> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3100015078 endingPage "118" @default.
- W3100015078 startingPage "115" @default.
- W3100015078 abstract "Introduction The COVID‐19 pandemic requires us all to re‐evaluate aesthetic practices to ensure optimal patient safety during elective procedures. Specifically, energy‐based devices and lasers require special consideration, as they may emit plume which has been shown to contain tissue debris and aerosolized biological materials. Prior studies have shown transmission of viruses and bacteria via plume (i.e., HIV and papillomavirus). The purpose of this study was to evaluate plume characteristics of the Er:YAG resurfacing laser (Sciton; Palo Alto, CA) and compare it to the Morpheus8 fractional radiofrequency device (InMode; Lake Forest, CA). Methods Five patients who underwent aesthetic resurfacing and/or skin tightening of the face and neck were treated with the Er:YAG (Sciton Joule, Palo Alto, CA) and/or fractional radiofrequency (Morpheus8, Lake Forest, CA) between April 1 and May 11, 2020. Data collected included patient demographics, past medical history, treatment parameters, adverse events, particle counter data, as well as high magnification video equiptment. Patients were evaluated during treatment with a calibrated particle meter (PCE; Jupiter, FL). The particle meter was used at a consistent focal distance (612 inches) to sample the surrounding environment during treatment at 2.83 L/min to a counting efficiency of 50% at 0.3 µm and 100% at >0.45 µm. Recordings were obtained with and without a smoke evacuator. Results Of our cohort ( n = 5), average age was 58 years old (STD ±7.2). Average Fitzpatrick type was between 2 and 3. Two patients received Er:YAG fractional resurfacing in addition to fractional radiofrequency during the same treatment session. Two patients had fractional radiofrequency only, and one patient had laser treatment with the Er:YAG only. There were no adverse events recorded. The particle counter demonstrated ambient baseline particles/second (pps) at 8 (STD ±6). During fractional radiofrequency treatment at 1‐mm depth, the mean recording was 8 pps (STD ±8). At the more superficial depth of 0.5 mm, recordings showed 10 pps (STD ±6). The Er:YAG laser resurfacing laser had mean readings of 44 pps (STD ±11). When the particle sizes were broken down by size, the fractional radiofrequency device had overall smaller particle sizes with a count of 251 for 0.3 µm (STD ±147) compared with Er:YAG laser with a count of 112 for 0.3 µm (STD ±84). The fractional radiofrequency did not appear to emit particles >5 µm throughout the treatment, however, the Er:YAG laser consistently recorded majority of particles in the range of 510 µm. The addition of the smoke evacuator demonstrated a 50% reduction in both particles per second recorded as well as all particle sizes. Conclusion Re‐evaluation of the plume effect from aesthetic devices has become important during the COVID‐19 pandemic. Further studies are required to characterize viability of COVID‐19 viability and transmissibility in plume specimens. Based on this pilot study, we recommend that devices that generate little to no plume such as fractional radiofrequency devices be used in Phase I reopening of practice while devices that generate a visible plume such as Er:YAG laser resurfacing devices be avoided and only used with appropriate personal protective equipment in addition to a smoke evacuator in Phase IV reopening." @default.
- W3100015078 created "2020-11-23" @default.
- W3100015078 creator A5028016439 @default.
- W3100015078 creator A5071144060 @default.
- W3100015078 creator A5074453904 @default.
- W3100015078 creator A5080606523 @default.
- W3100015078 date "2020-11-08" @default.
- W3100015078 modified "2023-09-29" @default.
- W3100015078 title "Plume Effect of Fractional Radiofrequency Verus Laser Resurfacing: Considerations in the COVID‐19 Pandemic" @default.
- W3100015078 cites W1975742162 @default.
- W3100015078 cites W1990144856 @default.
- W3100015078 cites W1994647173 @default.
- W3100015078 cites W2036032992 @default.
- W3100015078 cites W2039231692 @default.
- W3100015078 cites W2041863397 @default.
- W3100015078 cites W2045094147 @default.
- W3100015078 cites W2048477679 @default.
- W3100015078 cites W2076728464 @default.
- W3100015078 cites W2091143237 @default.
- W3100015078 cites W2094340006 @default.
- W3100015078 cites W2131475027 @default.
- W3100015078 cites W2141350698 @default.
- W3100015078 cites W2154298662 @default.
- W3100015078 cites W2419256944 @default.
- W3100015078 cites W2463341121 @default.
- W3100015078 cites W2947601245 @default.
- W3100015078 cites W2993127632 @default.
- W3100015078 cites W3013358680 @default.
- W3100015078 cites W3022692612 @default.
- W3100015078 cites W3025735759 @default.
- W3100015078 doi "https://doi.org/10.1002/lsm.23336" @default.
- W3100015078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33161606" @default.
- W3100015078 hasPublicationYear "2020" @default.
- W3100015078 type Work @default.
- W3100015078 sameAs 3100015078 @default.
- W3100015078 citedByCount "1" @default.
- W3100015078 countsByYear W31000150782023 @default.
- W3100015078 crossrefType "journal-article" @default.
- W3100015078 hasAuthorship W3100015078A5028016439 @default.
- W3100015078 hasAuthorship W3100015078A5071144060 @default.
- W3100015078 hasAuthorship W3100015078A5074453904 @default.
- W3100015078 hasAuthorship W3100015078A5080606523 @default.
- W3100015078 hasBestOaLocation W31000150781 @default.
- W3100015078 hasConcept C121332964 @default.
- W3100015078 hasConcept C141071460 @default.
- W3100015078 hasConcept C153294291 @default.
- W3100015078 hasConcept C2775840915 @default.
- W3100015078 hasConcept C2989005 @default.
- W3100015078 hasConcept C71924100 @default.
- W3100015078 hasConceptScore W3100015078C121332964 @default.
- W3100015078 hasConceptScore W3100015078C141071460 @default.
- W3100015078 hasConceptScore W3100015078C153294291 @default.
- W3100015078 hasConceptScore W3100015078C2775840915 @default.
- W3100015078 hasConceptScore W3100015078C2989005 @default.
- W3100015078 hasConceptScore W3100015078C71924100 @default.
- W3100015078 hasIssue "1" @default.
- W3100015078 hasLocation W31000150781 @default.
- W3100015078 hasOpenAccess W3100015078 @default.
- W3100015078 hasPrimaryLocation W31000150781 @default.
- W3100015078 hasRelatedWork W1586374228 @default.
- W3100015078 hasRelatedWork W2003938723 @default.
- W3100015078 hasRelatedWork W2047967234 @default.
- W3100015078 hasRelatedWork W2089201504 @default.
- W3100015078 hasRelatedWork W2118496982 @default.
- W3100015078 hasRelatedWork W2364998975 @default.
- W3100015078 hasRelatedWork W2369162477 @default.
- W3100015078 hasRelatedWork W2439875401 @default.
- W3100015078 hasRelatedWork W4238867864 @default.
- W3100015078 hasRelatedWork W2525756941 @default.
- W3100015078 hasVolume "53" @default.
- W3100015078 isParatext "false" @default.
- W3100015078 isRetracted "false" @default.
- W3100015078 magId "3100015078" @default.
- W3100015078 workType "article" @default.